Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

76.25
-3.6600-4.58%
Post-market: 76.250.00000.00%16:32 EST
Volume:307.45K
Turnover:23.69M
Market Cap:1.71B
PE:45.53
High:79.94
Open:79.90
Low:75.64
Close:79.91
52wk High:99.50
52wk Low:54.10
Shares:22.47M
Float Shares:20.38M
Volume Ratio:0.91
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.67
EPS(LYR):-1.0429
ROE:8.66%
ROA:2.37%
PB:3.39
PE(LYR):-73.11

Loading ...

Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 26, 2025

Major Issues Report

Form 8-K - Current report
Sep 08, 2025

Major Issues Report

Form 8-K - Current report
Sep 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities